Pete Yonkman, president of Cook Group and Cook Medical, was among the speakers Monday at the official launch of the new ...

John Lilly and the Earth Coincidence Control Office’ from Michael Almereyda and Courtney Stephens, narrated by Chloë Sevigny, debuts at Rotterdam, exploring the life of the utopian neuroscientist.

Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial Ph1 clinical data anticipated by end of 202 ...

BioAge has also entered a strategic collaboration with Lilly ExploR&D (part of Lilly Catalyze360) to discover two therapeutic antibodies that address novel metabolic aging targets identified by BioAge ...

Visible healing of the intestinal lining was observed in 46% of subjects treated with the therapy compared to placebo. Credit: SewCreamStudio/Shutterstock ...

Daniel Skovronsky, chief scientific officer and president of Lilly Research Laboratories and Lilly Immunology, said: “People living with Crohn’s disease have shared with us how truly disruptive ...

Eli Lilly has received approval from the US Food and Drug Administration (FDA) for Omvoh (mirikizumab-mrkz) to treat moderately to severely active Crohn's disease in the adult population.

The company’s Gateway Labs operate as co-working ... services that support investigational drug research and clinical development capabilities. Lilly Ventures focuses on “opportunities of ...

Skovronsky, M.D., Ph.D., chief scientific officer, and president of Lilly Research Laboratories and Lilly Immunology. "With Omvoh approved in both Crohn's disease and ulcerative colitis ...

Skovronsky, M.D., Ph.D., chief scientific officer, and president of Lilly Research Laboratories and Lilly Immunology. "With Omvoh approved in both Crohn's disease and ulcerative colitis, more patients ...